About Gracious Pharmaceuticals Private Limited
Data last updated:
Gracious Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52609MH2018PTC314515. Its GSTIN is 27AAHCG4850C1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Atul Prafulla Patil and Pramod Kumar Bharti.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Dg – 06 2nd Floor Plot – 11 Sector – 19D Vashi, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.36 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.6 Cr (net margin 9.8%) and EBITDA of ₹2.39 Cr (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 181% over three years and 297% over five years.
As per MCA filings, the company has open charges of ₹87.76 Lakh on record.
For more details, the company can be reached via its website graciouspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressDg – 06 2nd Floor Plot – 11 Sector – 19D Vashi, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gracious Pharmaceuticals Private Limited
The main business activity of Gracious Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gracious Pharmaceuticals Private Limited FY 2024 filings available
Gracious Pharmaceuticals Private Limited reported revenue of ₹16.36 Cr (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gracious Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 297% over five years, including 28% growth in the latest year. EBITDA rose 217% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gracious Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.39 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.6 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gracious Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gracious Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Gracious Pharmaceuticals Private Limited
Gracious Pharmaceuticals Private Limited is audited by SUTHAR PARAB & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUTHAR PARAB & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gracious Pharmaceuticals Private Limited
Gracious Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Prafulla Patil Also directs: Praj Lifescience LLP, Ravim Biotech Private Limited | Director | 20 Sep 2018 | 8 Years 0 Months | Current |
| Pramod Kumar Bharti Also directs: Praj Lifescience LLP, Ravim Biotech Private Limited | Director | 20 Sep 2018 | 8 Years 0 Months | Current |
| Nidhi Also directs: Ravim Biotech Private Limited | Director | 18 Jul 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Gracious Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gracious Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2025 | Others | ₹30.95 Lakh | Open |
| 07 Mar 2025 | Others | ₹56.82 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Gracious Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Gracious Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gracious Pharmaceuticals Private Limited
Gracious Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Nidhi ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Gracious Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gracious Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gracious Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gracious Pharmaceuticals Private Limited
Gracious Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG4850C1ZR | Maharashtra | Active | 03 Nov 2018 |
| 05AAHCG4850C1ZX | Uttarakhand | Active | 08 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gracious Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gracious Pharmaceuticals Private Limited
Gracious Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U52609MH2018PTC314515.
Gracious Pharmaceuticals reported revenue of ₹16.36 Cr for FY 2024 (up 28% YoY).
Gracious Pharmaceuticals has 3 current directors:
- Atul Prafulla Patil - Director
- Pramod Kumar Bharti - Director
- Nidhi - Director
Gracious Pharmaceuticals reported a net profit of ₹1.6 Cr (net margin 9.8%) and EBITDA of ₹2.39 Cr (EBITDA margin 14.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gracious Pharmaceuticals is 181% over three years and 297% over five years. In the latest year (FY 2024) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gracious Pharmaceuticals is 27AAHCG4850C1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAHCG4850C1ZX (Uttarakhand).
The CIN (Corporate Identification Number) of Gracious Pharmaceuticals is U52609MH2018PTC314515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gracious Pharmaceuticals was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Nidhi ceased to be Additional Director on 29 Sep 2024. Nidhi was appointed as Director on 18 Jul 2024. Atul Prafulla Patil was appointed as Director on 20 Sep 2018. Gracious Pharmaceuticals has 4 board changes on record in total.
Gracious Pharmaceuticals can be reached through the website graciouspharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.